U.S. Physical Therapy (USPH) Projected to Post Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) is expected to be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.67 per share and revenue of $200.0990 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:30 AM ET.

U.S. Physical Therapy Price Performance

USPH opened at $86.60 on Wednesday. The stock has a market cap of $1.32 billion, a P/E ratio of 36.39, a P/E/G ratio of 3.59 and a beta of 1.30. U.S. Physical Therapy has a 12 month low of $62.77 and a 12 month high of $93.50. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.30. The company has a fifty day simple moving average of $82.94 and a 200 day simple moving average of $82.32.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on USPH. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Barrington Research restated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Monday, January 5th. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Four analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $105.33.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds and other institutional investors have recently made changes to their positions in USPH. Dimensional Fund Advisors LP lifted its position in shares of U.S. Physical Therapy by 3.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 491,726 shares of the company’s stock worth $38,403,000 after purchasing an additional 17,482 shares in the last quarter. Schroder Investment Management Group increased its stake in U.S. Physical Therapy by 45.9% in the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock valued at $29,603,000 after buying an additional 114,618 shares during the last quarter. Geode Capital Management LLC lifted its position in U.S. Physical Therapy by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 355,237 shares of the company’s stock worth $27,746,000 after buying an additional 1,097 shares in the last quarter. Bank of America Corp DE lifted its position in U.S. Physical Therapy by 77.2% during the 3rd quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after buying an additional 138,194 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of U.S. Physical Therapy by 3.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 147,888 shares of the company’s stock worth $11,549,000 after buying an additional 5,207 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.